Hence, we investigated whether the heterogeneous distribution of endogenous CXCR4/ACKR3 receptors in our BC cell lines may correlate with ERK1/2 activation patterns in response to exogenous CXCL12. This evidence concerns the gene CXCL12 and breast cancer.